GLP1R and coronary artery disorder: Results of our study indicate that EAT volume per se does not discriminate patients with CAD from controls, but its biological activity, reflected by UCP-1 and GLP-1R expression, may provide insights into disease-specific remodeling of this visceral fat depot.